Pekin Hardy Strauss’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $382K | Sell |
7,937
-1,750
| -18% | -$81.6K | 0.04% | 336 |
|
|
2025
Q4 | $469K | Hold |
9,687
| – | – | 0.04% | 288 |
|
|
2025
Q3 | $457K | Hold |
9,687
| – | – | 0.05% | 266 |
|
|
2025
Q2 | $468K | Sell |
9,687
-175
| -2% | -$8.94K | 0.05% | 252 |
|
|
2025
Q1 | $547K | Hold |
9,862
| – | – | 0.07% | 236 |
|
|
2024
Q4 | $476K | Hold |
9,862
| – | – | 0.06% | 252 |
|
|
2024
Q3 | $568K | Sell |
9,862
-156
| -2% | -$8.42K | 0.07% | 227 |
|
|
2024
Q2 | $486K | Sell |
10,018
-679
| -6% | -$32.8K | 0.07% | 224 |
|
|
2024
Q1 | $520K | Sell |
10,697
-95
| -0.9% | -$4.64K | 0.07% | 211 |
|
|
2023
Q4 | $537K | Hold |
10,792
| – | – | 0.08% | 190 |
|
|
2023
Q3 | $579K | Sell |
10,792
-100
| -0.9% | -$5.33K | 0.09% | 182 |
|
|
2023
Q2 | $587K | Sell |
10,892
-131
| -1% | -$7.05K | 0.06% | 182 |
|
|
2023
Q1 | $600K | Sell |
11,023
-100
| -0.9% | -$4.86K | 0.08% | 184 |
|
|
2022
Q4 | $539K | Sell |
11,123
-121
| -1% | -$5.31K | 0.07% | 189 |
|
|
2022
Q3 | $427K | Sell |
11,244
-1,500
| -12% | -$66.8K | 0.07% | 198 |
|
|
2022
Q2 | $638K | Hold |
12,744
| – | – | 0.09% | 186 |
|
|
2022
Q1 | $654K | Sell |
12,744
-1,410
| -10% | -$72.8K | 0.08% | 202 |
|
|
2021
Q4 | $709K | Sell |
14,154
-1,725
| -11% | -$85.3K | 0.1% | 195 |
|
|
2021
Q3 | $766K | Sell |
15,879
-955
| -6% | -$48.6K | 0.11% | 188 |
|
|
2021
Q2 | $886K | Sell |
16,834
-55
| -0.3% | -$2.87K | 0.12% | 169 |
|
|
2021
Q1 | $835K | Sell |
16,889
-11,754
| -41% | -$565K | 0.13% | 153 |
|
|
2020
Q4 | $1.39M | Sell |
28,643
-2,495
| -8% | -$123K | 0.24% | 99 |
|
|
2020
Q3 | $1.56M | Buy |
31,138
+1,524
| +5% | +$78.5K | 0.32% | 81 |
|
|
2020
Q2 | $1.51M | Buy |
29,614
+21
| +0.1% | +$1.02K | 0.33% | 72 |
|
|
2020
Q1 | $1.29M | Sell |
29,593
-2,520
| -8% | -$121K | 0.29% | 74 |
|
|
2019
Q4 | $1.61M | Sell |
32,113
-2,500
| -7% | -$117K | 0.26% | 83 |
|
|
2019
Q3 | $1.6M | Sell |
34,613
-1,780
| -5% | -$76.8K | 0.31% | 74 |
|
|
2019
Q2 | $1.57M | Buy |
36,393
+73
| +0.2% | +$3.1K | 0.31% | 72 |
|
|
2019
Q1 | $1.61M | Sell |
36,320
-1,685
| -4% | -$72.2K | 0.13% | 68 |
|
|
2018
Q4 | $1.65M | Buy |
38,005
+215
| +0.6% | +$9.48K | 0.29% | 67 |
|
|
2018
Q3 | $1.69M | Sell |
37,790
-565
| -1% | -$24.1K | 0.29% | 71 |
|
|
2018
Q2 | $1.53M | Buy |
38,355
+1,315
| +4% | +$51.8K | 0.29% | 72 |
|
|
2018
Q1 | $1.49M | Buy |
+37,040
| New | +$1.54M | 0.27% | 74 |
|
Other funds holding SNY
MIP
Pekin Hardy Strauss's SNY Position: Q1 2026 in Review
Pekin Hardy Strauss reduced its Sanofi (SNY) stake by 18% in Q1 2026, selling an estimated $81.6K and leaving 7,937 shares worth $382K. The position accounts for 0.04% of the portfolio, ranked #336.
Pekin Hardy Strauss first reported a position in SNY in Q1 2018 and has held it in 33 quarters since. The position peaked at $1.69M in Q3 2018. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.
- Pekin Hardy Strauss held 7,937 shares of Sanofi worth $382K as of Q1 2026.
- Pekin Hardy Strauss sold 1,750 Sanofi shares in Q1 2026, an estimated $81.6K.
- Sanofi made up 0.04% of Pekin Hardy Strauss's portfolio in Q1 2026, its #336 holding.
- Pekin Hardy Strauss first reported a position in Sanofi in Q1 2018 and has held it in 33 quarters since.
- Pekin Hardy Strauss's Sanofi position peaked at $1.69M in Q3 2018.
- 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.
Based on Pekin Hardy Strauss's 13F filing for Q1 2026, filed 7 May 2026.